Full-Time

Associate AI/ML Engineer

Supply Chain Digitalization, AI & Automation

Solventum

Solventum

10,001+ employees

Global healthcare company: wound care, dental

No salary listed

Bengaluru, Karnataka, India

Hybrid

Hybrid role with 40% commuting to the office.

Bachelor's

Category
AI & Machine Learning (1)
Required Skills
LLM
Kubernetes
MLOps
Microsoft Azure
Python
Grafana
Forecasting
SQL
Machine Learning
MLflow
Data Engineering
OpenTelemetry
Docker
RAG
Microservices
AWS
Prometheus
LangGraph
REST APIs
LangChain
DevOps
Databricks

Get referred to Solventum

See people who can refer or advise you

Requirements
  • A bachelor's degree in computer science, Software Engineering, AI, or a related field and 2 to 4 years of professional experience in Machine Learning, Artificial Intelligence, Data Science, or AI Engineering, or a master's degree with relevant industry experience and 2 to 3 years of experience with internship experience.
  • At least 3 years of hands-on experience with Python and foundational knowledge of designing, developing, and supporting Machine Learning and AI solutions, including predictive modelling, forecasting, feature engineering, and model evaluation, ideally using Azure, Databricks, or AWS.
  • Exposure to or coursework or project experience with Generative AI applications and Agentic AI workflows using Lang Graph, Lang Chain, Auto Gen, Crew AI, or similar technologies.
  • Foundational understanding of Large Language Models, Prompt Engineering, Retrieval-Augmented Generation, and AI evaluation techniques, with willingness to deepen expertise in responsible AI practices.
  • Basic understanding of system design patterns, microservices architecture, application programming interfaces, containerization with Docker, Kubernetes, and infrastructure automation.
  • Familiarity with, or eagerness to learn, AI observability and evaluation tools such as Azure AI Foundry, Azure Monitor, Azure ML Monitoring, AWS CloudWatch, MLflow, Lang Smith, Prometheus, Grafana, or OpenTelemetry.
  • Exposure to enterprise data platforms, data pipelines, SQL, and distributed data processing frameworks to support AI/ML solutions.
Responsibilities
  • Assist in designing, developing, and deploying Machine Learning models and AI solutions to solve Supply Chain business challenges.
  • Contribute to end-to-end Machine Learning pipelines for forecasting, optimization, predictive analytics, anomaly detection, and intelligent automation under the guidance of senior team members.
  • Help ensure models are production-ready, reliable, and scalable.
  • Support the design, build, testing, and deployment of AI Agents and multi-agent systems using frameworks such as Lang Graph, Lang Chain, Auto Gen, Crew AI, or similar technologies.
  • Help develop intelligent workflows that leverage Large Language Models, tool integration, memory, and orchestration to automate business processes and improve operational decision-making.
  • Help develop data ingestion, transformation, and feature engineering pipelines for structured, semi-structured, and unstructured enterprise data.
  • Support integration of enterprise knowledge repositories, knowledge graphs, vector databases, and intelligent document processing solutions for contextual AI insights and scalable Machine Learning and Generative AI applications.
  • Assist in deploying and maintaining AI and Machine Learning applications on AWS and Microsoft Azure.
  • Support MLOps and LLMOps pipelines, including model versioning, continuous integration and continuous delivery, automated deployment, monitoring, and retraining.
  • Help evaluate and monitor Machine Learning models and Large Language Models using appropriate performance metrics.
  • Support efforts to improve model accuracy, reduce inference latency, optimize cloud resource utilization, and implement responsible AI practices.
  • Collaborate with Supply Chain stakeholders, Data Scientists, Software Engineers, Cloud Architects, Product Managers, and Digital Transformation teams to translate business requirements into AI/ML solutions.
  • Participate in code reviews, follow engineering standards, and help create technical documentation.
Desired Qualifications
  • Academic, internship, or project experience developing AI/ML solutions for Supply Chain, Retail, Healthcare, or other enterprise domains.

Solventum provides a wide range of healthcare products across four main areas: wound care and surgical supplies, dental and orthodontic tools, health information software, and purification filters for biopharmaceuticals. These products work by combining material science and data science to help hospitals manage patient records, prevent infections during surgery, and filter fluids for medical treatments like dialysis. Unlike many competitors, the company holds a massive portfolio of over 7,300 patents inherited from its history as a 3M division, allowing it to serve over 75% of U.S. hospitals. Its goal is to use this intellectual property and a disciplined business model to find new solutions for healthcare providers and grow within the global medical technology market.

Company Size

10,001+

Company Stage

IPO

Headquarters

Maplewood, Minnesota

Founded

2023

Get referred to Solventum

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 organic sales rose 9.5%, and management lifted EPS guidance to $7.10-$7.20.
  • Dental grew 15.2% organically in Q2 2026, showing pricing and product momentum.
  • Solventum exited nearly 70% of TSAs and targets 90% by end-2026.

What critics are saying

  • ERP advance orders inflated Q2 by about $125 million, and Q3 reverses.
  • HIS now faces separation, and AI-native competitors threaten revenue-cycle workflows by 2027.
  • Thermo Fisher's $4.1 billion filtration acquisition removes Solventum's fastest-growing cash engine.

What makes Solventum unique

  • Solventum controls 3M-origin IP, with 7,300 patents across MedSurg, dental, and filtration.
  • Its $200 million Eagan Innovation Hub centralizes wound care, sterilization, and digital health R&D.
  • Management expects nearly 20 launches through Q1 2028, anchoring category depth.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

8%
Yahoo Finance
Aug 20th, 2026
BrightSpring Health Services posts 23.9% revenue growth as Solventum and Inspire Medical face headwinds

BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.

Yahoo Finance
Aug 11th, 2026
Solventum beats Q2 estimates with $2.21B revenue, raises EPS guidance 10% amid HIS separation

Healthcare solutions provider Solventum reported second quarter revenue of $2.21 billion, up 2.2% year on year and ahead of analyst estimates of $2.15 billion. Non-GAAP profit of $2.55 per share beat consensus estimates by 33.8%. The company announced plans to separate its Health Information Systems business to focus on its MedSurg and Dental segments. Management said the move would allow the HIS unit to pursue AI-driven innovation whilst sharpening Solventum's focus as a pure-play MedTech company. Second quarter results were temporarily boosted by approximately $125 million in advanced orders placed ahead of a major ERP system transition, which management expects to reverse next quarter. The company raised its full-year adjusted EPS guidance to $7.15 at the midpoint, a 10% increase. Solventum is nearing completion of its separation from 3M.

Yahoo Finance
Aug 9th, 2026
Solventum raises 2026 outlook with 9.5% Q2 growth boosted by $125M advanced orders and $100M tariff refund

Solventum exceeded expectations in Q2, posting $2.2 billion in sales with 9.5% organic growth. However, this included roughly $125 million in advanced ERP-related orders and a $100 million tariff refund. Excluding these benefits, organic growth was approximately 4% and adjusted EPS was estimated at $1.73. The company raised its 2026 outlook, now expecting 2.5%–3% organic sales growth, a 22.2%–22.7% operating margin, adjusted EPS of $7.10–$7.20, and free cash flow of $200 million–$300 million. Third-quarter growth is expected to decline temporarily as the advanced orders reverse. Solventum also announced plans to separate its Health Information Systems business through a potential spin-off or sale, aiming to focus on its MedSurg and Dental segments.

PR Newswire
Aug 5th, 2026
Solventum Q2 sales up 9.5%, raises 2026 guidance and plans to separate Health Information Systems unit

Solventum reported second quarter 2026 sales of $2.2 billion, up 2.2% on a reported basis and 9.5% organically. The MedTech company posted GAAP diluted earnings per share of $0.53 and adjusted diluted EPS of $2.55, marking a 50.9% increase. Operating cash flow reached $227 million, whilst free cash flow totalled $144 million. The strong performance was driven by volume and product mix across all segments, including advance orders ahead of ERP cutovers. Solventum announced plans to separate its Health Information Systems business segment as part of its transformation strategy. The company raised its full-year 2026 guidance, increasing organic sales growth to 2.5% to 3.0%, adjusted EPS to $7.10 to $7.20, and free cash flow to $200 million to $300 million.

Yahoo Finance
Aug 2nd, 2026
Solventum appoints Neil Zieselman as chief accounting officer

Solventum has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed Mary Wilcox, who is retiring. Zieselman brings experience from Surgery Partners, Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya. He is a licensed CPA. The company's stock trades at $85.44. It has delivered a 9.5% return over the past week and 19.1% over the past year. For investors, Zieselman's background in healthcare and corporate finance may influence Solventum's financial controls, reporting quality, and regulatory engagement. His approach could shape disclosure practices and capital allocation commentary in future earnings calls. Interest payments are not well covered by earnings, making any changes under the new Chief Accounting Officer particularly important for risk assessment.